An RNA-binding protein decides if stem cells build bone or fat

With aging, mesenchymal stem cells (MSCs) — the progenitor cells responsible for forming new bone — progressively shift away from becoming bone-forming osteoblasts and toward becoming fat cells instead, contributing to age-related bone loss. The molecular switch governing this fate decision at the RNA level has been unclear. This study identifies one such switch.

Using mouse models, the researchers identified OTUD1, an RNA-binding protein, as a regulator of MSC fate. OTUD1 directly binds and stabilizes the mRNA encoding BMP2, a key osteogenic growth factor, thereby promoting bone-forming differentiation. Mice lacking OTUD1 developed normally — early skeletal development was unaffected — but progressively lost bone homeostasis with age, and showed worse bone loss in models of ovariectomy-induced and glucocorticoid-induced osteoporosis. Structural analysis showed that a specific disordered region of OTUD1 (not its enzymatic deubiquitinase domain) was responsible for RNA binding and osteogenic activity. Broader molecular profiling showed OTUD1 also stabilizes transcripts involved in collagen remodeling and extracellular matrix organization, supporting overall stem cell function.

Clinical relevance: this is a basic mechanistic study in mice, not a clinical trial — it does not yet translate into a treatment. But it identifies a specific, non-enzymatic RNA-stabilizing mechanism that protects against age- and steroid-related bone loss, distinct from the classical signaling pathways osteoporosis drugs currently target. For a field grappling with regenerative bone therapies and glucocorticoid-induced osteoporosis (relevant to patients on long-term corticosteroids, including some with autoimmune or inflammatory conditions), this adds a new candidate pathway — and a reminder that post-transcriptional RNA regulation, not just signaling and transcription factors, shapes whether stem cells build bone or fat.